Wall Street veteran Jeff Yastine just released this eye-opening presentation on a biotech firm he’s been following for over a year.
In a nutshell, this tiny company has developed a remarkable little medical device that could soon ignite a new age in medicine.
Bloomberg calls this type of device a “must-have, block-buster product.”
Harvard Medical School claims most people won’t “buy just one” of these devices. They’ll “have them all over the place … the car, the office, school, a pocket and a purse.”
And experts tell CNBC, this device will “double the lives of patients that are carrying [one].”
Yastine estimates this device could soon be in the homes of 54 million Americans.
For investors in this company’s $5 stock – the rewards could be tremendous.
As Yastine revealed in a recent interview: “it’s stock price could double, even triple overnight if it’s acquired as I expect it to be.”
This is a time-sensitive situation – Yastine believes an announcement is imminent and could come at any moment.
To find out how to access all of his research just click here to read his special briefing right away…
Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest — you can lose some or all of your money. Never risk more than you can afford to lose. |
About Total Wealth Insider
Total Wealth Insider is one America’s leading financial newsletter research advisories. Jeff Yastine’s philosophy in Total Wealth Insider is simple yet proven: Buy overlooked investments that no one else is talking about. From little-known cybersecurity companies and green energy stocks … to infrastructure and gold plays … to technology and biotech stocks. Each month, Jeff exposes a world of opportunities so his subscribers can generate profits most people only dream about.